Identity and Access Management 2020
Healthcare Looks (Well) beyond SSO (A Decision Insights Report)

Author
Joe VanDeGraaff

Author
Dan Czech

December 3, 2020 | Read Time: 15 minutes

As healthcare continues its measured move to the cloud, healthcare provider organizations can no longer protect data solely through firewalls and strong perimeter defenses—the digital identity must be protected as well. With organizations replacing homegrown identity and access management (IAM) solutions with commercial options, new vendors have entered the healthcare arena, and longstanding single sign-on (SSO) vendors have expanded their suites. To understand which vendors are being replaced, considered, and purchased and what factors drive these decisions, this report combines customer satisfaction insights with feedback from 40 unique healthcare provider organizations that have recently made an IAM technology purchase decision.

to see the full dataset.

if you don't have a login, getting started is easy.

Provider Organizations

Fill out our registration form to verify your organization.

HIT Companies

Contact a KLAS representative for plans and pricing.

Key Findings:

KLAS Identity and Access Management Framework
Healthcare-Focused Vendors Expanding beyond SSO: Imprivata Makes Strong Initial Leap; Identity Automation Sees Minimal Traction
Among Cloud-Based Options Duo Carves Out a Niche; Microsoft IAM Clients in Limbo
Identity Governance: SailPoint Stands Out as Leading Choice
Long-Standing Vendors IBM, Micro Focus, Oracle Diminish in New Considerations
Top-Considered Vendors at a Glance

Writer
Elizabeth Pew

Designer
Jess Wallace-Simpson

Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2022 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.